The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.

Abstract:

BACKGROUND/AIM:Since androgens affect urothelial bladder cancer (UBC), we examined whether 5α-reductases (5-AR) have genomic alterations in UBC and whether 5α-reductase inhibitors (5-ARI) affect UBC. MATERIALS AND METHODS:The cBioPortal was used to analyze genomic alternations of 5-ARs in UBC cancer genomic datasets. Next, we used the Taiwan National Health Insurance Research database to conduct a population-based case-control study to investigate the effect of a 5-ARI, finasteride on UBC incidence. We also performed an XTT assay to examine the direct effect of finasteride on UBC cells. RESULTS:We found that 5-AR genomic alternations were observed in 29% of UBC patients and patients with alternations had shorter disease-free survival. Also, the use of finasteride with >180 cDDDs reduced the risk of UBC. Finasteride could directly inhibit UBC cell growth. CONCLUSION:Based on our findings, we concluded that 5-AR could be explored as a therapeutic target for UBC with 5-ARIs.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Chen CC,Huang CP,Tsai YT,Hseih TF,Shyr CR

doi

10.21873/anticanres.12152

subject

Has Abstract

pub_date

2017-12-01 00:00:00

pages

6893-6898

issue

12

eissn

0250-7005

issn

1791-7530

pii

37/12/6893

journal_volume

37

pub_type

杂志文章
  • Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.

    abstract::The proteasome inhibitor, bortezomib, is known to be effective in the therapy of various neoplasms. The objective of this study was the analysis of the ex vivo activity of bortezomib in paediatric acute lymphoblastic leukaemia (ALL), in comparison to paediatric acute myeloid leukaemia (AML). A total of 159 patients en...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Szczepanek J,Pogorzala M,Konatkowska B,Juraszewska E,Badowska W,Olejnik I,Kuzmicz M,Stanczak E,Malinowska I,Stefaniak J,Sobol G,Szczepanski T,Czyzewski K,Wysocki M,Styczynski J

    更新日期:2010-06-01 00:00:00

  • Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.

    abstract::CEA is discussed as a potential tumour marker for carcinomas of the urothelium. However, investigations by means of polyclonal antibodies have shown various cross reactions which are not to be expected with monoclonal antibodies (MAb). Immunohistochemistry was done with the MAb anti-CEA BW 431/26 (Behring), N 1522 (Da...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Feil G,Wechsel HW,Nelde HJ,Bichler KH

    更新日期:1999-07-01 00:00:00

  • Activity of CuDIPS against mammary cancer in C3H HeNCR mice.

    abstract::A copper complex with superoxide dismutase mimetic activity, Cu(II)2 (3,5-diisopropylsalicylate)4 (CuDIPS), was tested for activity against mammary cancer in female C3H/HeNCR mice. Initiation of treatment at 20 or at 30 weeks of age had a limited beneficial effect on survival rates. Further, a small, but not statistic...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Crispens CG Jr,Sorenson JR

    更新日期:1992-07-01 00:00:00

  • Effect of antitumor agents on cytotoxicity induction by sodium fluoride.

    abstract::We have recently found that sodium fluoride (NaF) induced apoptotic cell death in tumor cell lines. We investigated here whether 6 popular antitumor compounds modify the cytotoxic activity of NaF against human squamous cell carcinoma (HSC-2) and human promyelocytic leukemia (HL-60) cell lines. Cytotoxic concentrations...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Morshed SR,Tokunaga T,Otsuki S,Takayama F,Satoh T,Hashimoto K,Yasui T,Okamura M,Shimada J,Kashimata M,Sakagami H

    更新日期:2003-11-01 00:00:00

  • Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma.

    abstract::MDL 103,323, an enclomiphene analog, was tested for binding to the estrogen receptor, inhibition of human tumor xenografts and prevention of carcinogen-induced mammary tumors. MDL 103,323 had 5-6 fold greater affinity for the human estrogen receptor than did either tamoxifen or enclomiphene. Consistent with enhanced b...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bitonti AJ,Baumann RJ,Bush TL,Cashman EA,Wright CL,Prakash NJ

    更新日期:1996-09-01 00:00:00

  • Clarification of the functional significance of human folate-binding protein-alpha, peptide 191-199, based on a correct GenBank sequence and on other FBP (191-199) sequences.

    abstract::It has been brought to our attention that one of the folate binding protein (FBP) peptides, which we reported first as antigenic and immunogenic in cancer patients, the FBP 191-199, is "off by one amino acid from the amino acid sequence that is listed in GenBank". We searched the published information on FBP and found...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ioannides CG

    更新日期:2007-07-01 00:00:00

  • Vitamin D-24-hydroxylase in benign and malignant breast tissue and cell lines.

    abstract::Tissue-specific expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alpha-OHase) and vitamin D-hydroxylase (24-OHase) may act as the pivotal link between 25-hydroxyvitamin D3 (25(OH)D3) serum levels and the anticancer effects of 1,25-dihydoxyvitamin D3 (1,25(OH)2D3) and alternative splicing of the enzymes may regul...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fischer D,Becker S,Cordes T,Bücker B,Diedrich K,Friedrich M,Salehin D,Thill M

    更新日期:2009-09-01 00:00:00

  • The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer.

    abstract:BACKGROUND:Pulmonary complications (PCs) after esophagectomy for patients with esophageal cancer have been correlated with prolonged hospital stays and in-hospital mortality. Previous studies have shown that minimally-invasive esophagectomy (MIE) is associated with a lower rate of PCs compared to conventional open surg...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kubo N,Ohira M,Yamashita Y,Sakurai K,Toyokawa T,Tanaka H,Muguruma K,Shibutani M,Yamazoe S,Kimura K,Nagahara H,Amano R,Ohtani H,Yashiro M,Maeda K,Hirakawa K

    更新日期:2014-05-01 00:00:00

  • Expression of E-cadherin and catenins in invasive mammary carcinomas.

    abstract::E-Cadherin has been shown to be an invasion tumor suppressor gene, but few epidemiological studies have revealed relationships between loss of E-cadherin expression and invasive tumor growth and/or metastasis. The adhesive function of E-cadherin is dependent on the integrity of the catenin components which link E-cadh...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zschiesche W,Schönborn I,Behrens J,Herrenknecht K,Hartveit F,Lilleng P,Birchmeier W

    更新日期:1997-01-01 00:00:00

  • Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.

    abstract::The development of multidrug resistance (MDR) causes difficulties in the chemotherapy of of human cancer. Investigation of the possibility of reversal of MDR has been greatly aided by the use of cell lines with acquired resitance to anticancer agents in vitro or transfected with the mdrl gene. The aim of this study wa...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gyémánt N,Tanaka M,Molnár P,Deli J,Mándoky L,Molnár J

    更新日期:2006-01-01 00:00:00

  • Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.

    abstract::We carried out a systematic review of new drugs active in non-small cell lung carcinoma (NSCLC). Fifty five phase II and III trials were reviewed (vinorelbine (19 trials), paclitaxel (15), gemcitabine (11), docetaxel (6), topotecan (2) or irinotecan (2)). The first four ones could be considered as active drugs when gi...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Meert AP,Berghmans T,Branle F,Lemaître F,Mascaux C,Rubesova E,Vermylen P,Paesmans M,Sculier JP

    更新日期:1999-09-01 00:00:00

  • Expression of ets-1 and ets-2 in colonic neoplasms.

    abstract:BACKGROUND:Investigation of transcription regulators in carcinoma can contribute greatly to clarifying the biological character of the carcinoma. In this study, we examined the expression of ets-1 and ets-2, prominent transcription regulators belonging to the ets family, in various colonic tissues. MATERIALS AND METHO...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ito Y,Takeda T,Okada M,Matsuura N

    更新日期:2002-05-01 00:00:00

  • Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patients.

    abstract:BACKGROUND:Basic fibroblast growth factor (bFGF) is a potent angiogenetic factor which may influence breast cancer evolution. MATERIALS AND METHODS:Serum bFGF, (cut-off 10 pg/ml), was assayed in 166 breast cancer patients at all stages and compared with CA 15.3. RESULTS:In 99 pre-treatment (PT) sera, 39/99 (39.4%) we...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pichon MF,Moulin G,Pallud C,Pecking A,Floiras JL

    更新日期:2000-03-01 00:00:00

  • Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over.

    abstract:BACKGROUND:This retrospective study aimed to determine the efficacy and toxicity of a combined chemotherapeutic regimen of gemcitabine and cisplatin (GC) for the treatment of metastatic urothelial carcinomas (UCs) in patients 80 years of age and over. PATIENTS AND METHODS:Twelve patients who were at least 80 years old...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tanji N,Fukumoto T,Miura N,Yanagihara Y,Azuma K,Sasaki T,Nishida T,Kikugawa T,Shimamoto K,Aoki K,Yokoyama M

    更新日期:2010-09-01 00:00:00

  • Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients.

    abstract:BACKGROUND:Venous thromboembolism (VTE) is associated with cancer. Cancer patient with thromboembolism have poorer prognosis. This study assessed the risk and mortality in pancreatic cancer patients who develop VTE. PATIENTS AND METHODS:A retrospective chart review was performed of 201 patients with pancreatic cancer....

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shaib W,Deng Y,Zilterman D,Lundberg B,Saif MW

    更新日期:2010-10-01 00:00:00

  • Novel Extracorporeal Hemoperfusion System for Hepatic Arterial Infusion of Cisplatin.

    abstract:BACKGROUND/AIM:Hepatic venous isolation and extracorporeal charcoal hemoperfusion (HVI-CHP) can reduce systemic exposure to hepatic arterial infusion (HAI) chemotherapy. The pre-existing HVI-CHP system has limited effectiveness against high-dose cisplatin; therefore, we designed a new system and evaluated its efficacy ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13006

    authors: So S,Komatsu S,Takebe A,Kido M,Tanaka M,Toyama H,Ueno K,Fukumoto T

    更新日期:2018-11-01 00:00:00

  • Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.

    abstract::Thirty human renal cell carcinomas and 94 non-small cell lung carcinomas of previously untreated patients were analyzed for the presence of P-glycoprotein, glutathione S-transferase-pi and topoisomerase II by means of immunohistochemistry. In the renal cell carcinomas investigated, two resistance markers were seen in ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Volm M,Mattern J,Efferth T,Pommerenke EW

    更新日期:1992-07-01 00:00:00

  • Effect of genetic polymorphisms related to DNA repair and the xenobiotic pathway on the prognosis and survival of gastric cancer patients.

    abstract:BACKGROUND:A number of association studies have focused on the effect of polymorphisms related to DNA repair or the xenobiotic pathway, on the susceptibility to gastric cancer (GC). Here, the possible association between common polymorphisms in the X-ray repair cross-complementing groups (XRCC) 1, and glutathione-S-tra...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tahara T,Shibata T,Nakamura M,Yamashita H,Yoshioka D,Okubo M,Yonemura J,Ishizuka T,Maruyama N,Kamano T,Kamiya Y,Fujita H,Nakagawa Y,Nagasaka M,Iwata M,Yamada H,Hirata I,Arisawa T

    更新日期:2011-02-01 00:00:00

  • 5-FU split dose; a phase I/II and pharmacokinetic study of a different schedule of the Nordic regimen in advanced colorectal carcinoma.

    abstract:PURPOSE:Despite more than four decades of fluoro-pyrimidine treatment in different cancers, the optimal schedule is still not known. The plasma half-life of 5-fluorouracil (5-FU) is extremely short and continuous infusion has gained popularity. In this study we explored whether repeated bolus 5-FU injections could impr...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Berglund A,Carlsson G,Gustavsson B,Frödin JE,Ragnhammar P,Glimelius B

    更新日期:2003-03-01 00:00:00

  • Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.

    abstract:BACKGROUND/AIM:The purpose of this study was to identify adverse prognostic factors for patients with advanced esophageal cancer undergoing chemotherapy with docetaxel, cisplatin and 5-fluorouracil (DCF). PATIENTS AND METHODS:The study cohort comprised of 45 patients with advanced esophageal cancer who underwent induc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12302

    authors: Nakajima M,Muroi H,Kikuchi M,Takahashi M,Ihara K,Shida Y,Kurayama E,Ogata H,Yamaguchi S,Sasaki K,Sakai M,Sohda M,Miyazaki T,Kuwano H,Kato H

    更新日期:2018-02-01 00:00:00

  • Augmented pro-apoptotic effects of TRAIL and proteasome inhibitor in human promonocytic leukemic U937 cells.

    abstract::TRAIL, Tumor necrosis factor-related apoptosis-inducing ligand), a member of the TNF family, is known to be cytotoxic for a high proportion of tumor cell lines. However, successful application of TRAIL in tumor therapy may depend on finding other agents that can potentiate its antitumor effects. The present study show...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Młynarczuk I,Hoser G,Grzela T,Stokłosa T,Wójcik C,Malejczyk J,Jakóbisiak M

    更新日期:2001-03-01 00:00:00

  • Effect of PSC 833 on the efficacy of doxorubicin in vitro in a medullary thyroid carcinoma cell line.

    abstract::In medullary carcinoma of the thyroid (MTC), multidrug resistance (MDR) remains the major obstacle to effective chemotherapy. In this work MDR was investigated in TT cells, a human MTC cell line. We studied the effect of an efficient MDR agent (SDZ PSC 833) on doxorubicin (DOX)-induced cytotoxicity in TT cells culture...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Massart C,Gibassier J,Denais A,Genetet N

    更新日期:1998-07-01 00:00:00

  • Intraductal tubular carcinoma of the pancreas: case report with review of literature.

    abstract::A 67-year-old man presented with leg edema. Laboratory data showed elevated blood glucose and carbohydrate antigen (CA) 19-9 levels, and anemia. Further imaging studies revealed a relatively clear-margined tumor totally occupying the main pancreatic duct (MPD) from the head to the tail of the pancreas (maximum diamete...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hioki M,Nakagohri T,Ikumoto T,Gotohda N,Takahashi S,Konishi M,Kojima M,Kinoshita T

    更新日期:2010-11-01 00:00:00

  • Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.

    abstract:BACKGROUND:Several studies have supported the hypothesis that the concept of immuno-surveillance would not be effective in cancer patients. One reason for suppression of antitumor immunity may be attributed to immune impairment of T-lymphocytes, which extends beyond the tumor-microenvironment and might effect the perip...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gruber IV,El Yousfi S,Dürr-Störzer S,Wallwiener D,Solomayer EF,Fehm T

    更新日期:2008-03-01 00:00:00

  • Oxazolinodoxorubicin - a promising new anthracycline.

    abstract::Oxazolinodoxorubicin, a doxorubicin analog with a modified daunosamine moiety was synthesized. The properties of this compound and the parent doxorubicin were compared. The cytotoxicity in vitro studies against several human tumor cell lines (PC-3, MCF-7, SW707, HL-60, RPMI 8226, ACHN) showed higher antiproliferative ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lukawska M,Klopotowska D,Milczarek M,Wietrzyk J,Studzian K,Szmigiero L,Porebska A,Oszczapowicz I

    更新日期:2012-07-01 00:00:00

  • p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium.

    abstract::An immunohistochemical study of 155 squamous cell carcinomas of the oesophagus, squamous epithelium adjacent to the tumour (n = 80), dysplastic epithelium (n = 16) and controls (n = 23) indicates that Ki67 and p53 expression is frequently present in premalignant oesophageal lesions and their related squamous cell carc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Jaskiewicz K,De Groot KM

    更新日期:1994-01-01 00:00:00

  • Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.

    abstract:BACKGROUND/AIM:To clarify whether renal dysfunction affects the incidence of adverse events associated with oxaliplatin, the present study was designed to investigate the relationship between creatinine clearance (Ccr) and the incidence of oxaliplatin-related adverse events. PATIENTS AND METHODS:A total of 287 CRC pat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13953

    authors: Watanabe D,Fujii H,Yamada Y,Iihara H,Ishihara T,Matsuhashi N,Takahashi T,Yoshida K,Suzuki A

    更新日期:2020-01-01 00:00:00

  • Nicotine Exposure Augments Renal Toxicity of 5-aza-cytidine Through p66shc: Prevention by Resveratrol.

    abstract:BACKGROUND/AIM:We have shown that either chronic nicotine (NIC) exposure or 5-aza-cytidine (AZA) augments oxidative stress-dependent injury through stimulating p66shc in renal cells. Hence, NIC could exacerbate adverse effects of AZA while antioxidants such as resveratrol (RES) could prevent it. MATERIALS AND METHODS:...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11793

    authors: Arany I,Hall S,Faisal A,Dixit M

    更新日期:2017-08-01 00:00:00

  • Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.

    abstract::The dimers bis-EUG, bis-MMP, bis-BHA, bis-BMP and bis-DBP were synthesized from the monomers 4-allyl-2-methoxyphenol (EUG), 2-methoxy-4-methylphenol (MMP), 2-t-butyl-4-methoxyphenol (BHA), 2-t-butyl-4-methylphenol (BMP) and 2,4-di-t-butylphenol (DBP), respectively. The stoichiometric factors (n; number of free radical...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fujisawa S,Atsumi T,Kadoma Y,Ishihara M,Ito S,Yokoe I

    更新日期:2004-09-01 00:00:00

  • The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.

    abstract:BACKGROUND:Deregulated RAS/RAF/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC). This study aimed to test the inhibitory effects of PI-103 (a small molecule inhibitor of PI3K and mTOR) and sorafenib as single agents and in combination on HCC tumorigenesis in an in vivo xenograft mod...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gedaly R,Angulo P,Chen C,Creasy KT,Spear BT,Hundley J,Daily MF,Shah M,Evers BM

    更新日期:2012-07-01 00:00:00